What is driving the substantial revenue growth for Intuitive Surgical?

The primary driver of revenue growth is the increasing adoption of the da Vinci Surgical System across various surgical specialties, particularly in urology (prostatectomy) and gynecology (hysterectomy). This adoption leads to higher sales of the systems themselves, as well as increased recurring revenue from instruments, accessories, and service contracts.

How is the company managing its exposure to auction rate securities?

Intuitive Surgical holds approximately $91 million in municipal bonds with auction reset features (auction rate securities) that have experienced auction failures. While these are currently classified as long-term assets and valued at fair value, the company is monitoring the situation closely. They do not anticipate this lack of liquidity to impact their ability to execute their business plan, given their strong operating cash flows and other liquid investments.

What is the significance of the increase in recurring revenue?

The growing portion of recurring revenue (instruments, accessories, and services) is crucial as it often carries higher gross margins than system sales and provides a more predictable revenue stream. This trend indicates increasing utilization of the installed base of da Vinci systems and a potential for more sustainable, long-term profitability.

How are stock-based compensation expenses impacting the financial results?

Stock-based compensation expense has increased significantly in Q1 2008, impacting operating costs across cost of revenue, SG&A, and R&D. While this increases reported expenses, it also reflects the company's strategy to incentivize employees through equity. Investors should note this non-cash expense when evaluating operating income and net income trends.

ISRG 10-Q Quarterly Report Q1 FY2008 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) demonstrated robust financial performance in the first quarter of 2008, reflecting continued strong adoption of its da Vinci Surgical System. Revenue surged by 65% year-over-year to $188.2 million, driven by a significant increase in both system sales and recurring revenue from instruments, accessories, and services. The company sold 74 da Vinci systems, up from 44 in the prior year's quarter, and maintained a strong operating margin of 34%. Financially, ISRG reported substantial growth in net income, which rose to $44.8 million, or $1.12 per diluted share, from $23.8 million, or $0.62 per diluted share, in the same period last year. The company's balance sheet remains strong, with cash and investments increasing significantly, providing ample liquidity for ongoing operations and future growth initiatives. Despite exposure to auction rate securities, which are being managed, the company's operational cash flow generation is robust.

Key Highlights

1Revenue increased by 65% year-over-year to $188.2 million, driven by strong sales of da Vinci Surgical Systems and recurring revenue streams.
2Net income grew significantly to $44.8 million ($1.12 per diluted share) from $23.8 million ($0.62 per diluted share) in Q1 2007.
3The company sold 74 da Vinci Surgical Systems in Q1 2008, a 68% increase compared to 44 systems in Q1 2007.
4Recurring revenue (instruments, accessories, and services) grew 53% to $89.1 million, now representing 47% of total revenue.
5Operating income rose by 89% to $64.9 million, with operating margin improving to 34% from 30% year-over-year.
6Cash, cash equivalents, and investments increased to $699.7 million at the end of the quarter, indicating strong liquidity.
7The company reported a significant increase in stock-based compensation expense, impacting operating costs but reflecting growth in employee equity incentives.

INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2008

Summary

Key Highlights

Frequently Asked Questions